RARA CRAFT DATABASE for FDA Medical Devices
510(k)K221005

FDA DEVICE FACTS

EEA Circular Stapler with Tri-Staple Technology

Covidien

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 29, 2022PRODUCT CODEGDW

Indications for use

The EEA™ Circular Stapler with Tri -Staple™ Technology has application throughout the alimentary tract for the creation of end- to-end, end-to-side and side-to-side anastomoses in both open and laparoscopic surgeries.

Technological and Performance Characteristics: The subject EEA™ Circular Stapler with Tri- Staple™ Technology with a new contraindication does not change the fundamental operating principle and mechanism of action when compared to the predicate device. T his Special 510(k) submission is triggered by the addition of a contraindication called for in the Labeling Guidance: a statement noting that the device “should not be used to staple tissues that are necrotic, friable, or have altered integrity, e.g., ischemic or edematous tissues.” This contraindication is consistent with surgical training and practice. All EEA™ circular stapler s with Tri-Staple™ technology are single-use manual circular staplers.

Substantial Equivalent: The subject device with a new contraindication is substantially equivalent to the legally marketed EEA™ Circular Stapler with Tri- Staple™ Technology (K202507, K192330, K172361). The intended use, or indications of the subject device is not altered with the introduction of new contraindication.

They are same in fundamental scientific technology in that they are all sterile, single use, hand-held, manual surgical instruments equipped with titanium staples intended to be used during open or laparoscopic surgical procedures of the alimentary tract, to create anastomoses (end- to-end, end-to-side, or side -to-side) via intraluminal (within the lumen) resection. The subject and predicate devices are same in design, materials and are sterilized via ethylene oxide.

Summary of Studies: Non-clinical performance data – Usability assessment was performed for the proposed labeling changes to demonstrate substantial equivalence to the predicate device. Clinical performance data – No clinical study is deemed necessary since the substantial equivalence has been sufficiently demonstrated by non-clinical studies.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026